Physician profile
Hitham Tayoun
NPI 1881643492
$3,695.34
in general payments reported to CMS, 2019-2025
6 companies · $103 in 2025
The $103 reported for 2025 was more than what a typical Cytopathology provider received nationally (typical 2025 total: $55.75).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,273 · 2023: $2,319 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,422.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $3,541.12 | 2022-2023 | Xeomin |
| Olympus America INC. | $45.66 | 2025 | Itind System |
| Medtronic, INC. | $37.26 | 2025 | V-Loc 180 |
| Abbvie INC. | $28.56 | 2023 | Botox |
| Axonics, INC. | $22.17 | 2023 | Axonics |
| Myriad Genetic Laboratories, INC. | $20.57 | 2025 | Prolaris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hitham Tayoun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.